health
Trump is right to rebalance global drug prices
Americans pay the highest prices in the world for brand-name prescription drugs. Patients in other wealthy countries, meanwhile, pay far less for the exact same treatments. Their government-run health systems bully drug companies into offering huge discounts, and then the United States is left subsidizing drug costs for the rest of the world.
TL;DR
- Americans pay the highest prices globally for brand-name prescription drugs.
- Other wealthy countries pay significantly less for the same medications.
- The US government subsidizes drug costs for the rest of the world due to lower prices abroad.
- The Trump administration is pushing for other wealthy allies to reform their drug-pricing practices.
- A recent deal with the UK compelled increased spending on medicines as a share of GDP.
- Balanced global pricing is expected to increase sales opportunities for American pharmaceutical companies.
- This rebalancing is intended to incentivize companies to invest in research and development of new treatments.
- Immunotherapies are highlighted as a success story of medical breakthroughs driven by research incentives.
- The article argues that foreign countries capping prices or demanding discounts forces American patients and taxpayers to bear the cost of drug development.
- The administration's efforts are seen as a step towards a fairer system where other countries pay equitable prices for research-driven innovations.